These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16191413)

  • 1. Cytokine and immuno-gene therapy for solid tumors.
    Li CY; Huang Q; Kung HF
    Cell Mol Immunol; 2005 Apr; 2(2):81-91. PubMed ID: 16191413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat-inducible amplifier vector for high-level expression of granulocyte-macrophage colony-stimulating factor.
    Dammeyer P; Jaramillo MC; Pipes BL; Badowski MS; Tsang TC; Harris DT
    Int J Hyperthermia; 2006 Aug; 22(5):407-19. PubMed ID: 16891243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells and cytokines in immunotherapy and gene therapy of cancer.
    Pawelec G; Rees RC; Kiessling R; Madrigal A; Dodi A; Baxevanis C; Gambacorti-Passerini C; Masucci G; Zeuthen J
    Crit Rev Oncog; 1999; 10(1-2):83-127. PubMed ID: 10327211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in viral-vector systemic cytokine gene therapy against cancer.
    Liu L; Wang S; Shan B; Sang M; Liu S; Wang G
    Vaccine; 2010 May; 28(23):3883-7. PubMed ID: 20371389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of malignant tumors. Prospects of cytokine gene transfer vaccines].
    Bubeník J
    Cas Lek Cesk; 1997 Jan; 136(1):17-21. PubMed ID: 9147847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM-CSF-armed, replication-competent viruses for cancer.
    Burke JM
    Cytokine Growth Factor Rev; 2010; 21(2-3):149-51. PubMed ID: 20381405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment.
    Hunt KK; Vorburger SA
    Science; 2002 Jul; 297(5580):415-6. PubMed ID: 12130788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine therapy for cancer.
    Kim-Schulze S; Taback B; Kaufman HL
    Surg Oncol Clin N Am; 2007 Oct; 16(4):793-818, viii. PubMed ID: 18022545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutics in development for prostate cancer.
    Harzstark AL; Small EJ
    Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of cancer by cytokines mediated by gene therapy approach.
    Qian C; Liu XY; Prieto J
    Cell Res; 2006 Feb; 16(2):182-8. PubMed ID: 16474432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine gene transfer for the treatment of cancer.
    Bruyns C; Gérard C; Velu T
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S17-20. PubMed ID: 8177710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-based therapy and biochemotherapy for advanced melanoma.
    Atkins MB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Yamaue H
    Int J Oncol; 2007 Oct; 31(4):931-9. PubMed ID: 17786327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer immunotherapy.
    McNeel DG
    Curr Opin Urol; 2007 May; 17(3):175-81. PubMed ID: 17414515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine cytokine adjuvants in cancer immunotherapy.
    Pardoll DM
    Annu Rev Immunol; 1995; 13():399-415. PubMed ID: 7612229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.